Individual cases had focal MGP expression in renal cell carcinoma (6/121, 5.0%), ovarian carcinoma (7/290, 2.4%), lung adenocarcinoma (2/297, 0.7%), urothelial carcinoma (2/218, 0.9%) and cholangiocarcinoma (1/163, 0.6%), as shown in Fig. 6. This evidence concerns the gene MGP and ovarian carcinoma.